Recent research into respiratory disease in cats has identified a bacterium, called Bordetella bronchiseptica, that is increasingly being recognised as a risk to the cat population, particularly those in multicat environments including boarding and breeding catteries and rescue shelters. In addition contact with dogs can also lead to infection with Bordetella bronchiseptica.

Nobivac Bb for Cats is licensed for the active immunisation of cats, of 1 month of age or older, to reduce clinical signs of Bordetella bronchiseptica associated upper respiratory tract disease.

Nobivac Bb for cats contains ≥10^6.3  CFU/dose of the attenuated strain BC-2 of Bordetella bronchiseptica. For uses, dosage, contra-indications and warnings, see datasheet.  Nobivac Bb may only be prescribed and administered by your veterinary surgeon from whom advice should be sought.  Further information is available on request.